Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy

被引:2
|
作者
Arouche-Delaperche, L. [1 ]
Cadoni, S. [1 ]
Joffrois, C. [1 ]
Labernede, G. [1 ]
Valet, M. [1 ]
Cesar, Q. [1 ]
Degardin, J. [1 ]
Girardon, S. [2 ]
Gabriel, C. [3 ]
Krantic, S. [4 ]
Picaud, S. [1 ]
机构
[1] Sorbonne Univ, Inst Vis, INSERM, CNRS, 17 Rue Moreau, F-75012 Paris, France
[2] Inst Rech Servier, 125 Chemin Ronde, F-78290 Croissy Sur Seine, France
[3] Inst Rech Internatl Servier, 50 Rue Carnot, F-92284 Suresnes, France
[4] Sorbonne Univ, INSERM UMRS 938, Ctr Rech St Antoine, CRSA, 184 Rue Faubourg St Antoine, F-75012 Paris, France
基金
欧洲研究理事会;
关键词
Retina; Phosphorylated tau; Alzheimer's disease; P301S mouse; Synapsis; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; MEMORY DEFICITS; TAU; MICE; NETWORK; HYPEREXCITABILITY; ABNORMALITIES; IMPAIRMENT; RELEASE;
D O I
10.1186/s40478-022-01489-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tauopathies, including Alzheimer's disease, are characterized by retinal ganglion cell loss associated with amyloid and phosphorylated tau deposits. We investigated the functional impact of these histopathological alterations in the murine P301S model of tauopathy. Visual impairments were demonstrated by a decrease in visual acuity already detectable at 6 months, the onset of disease. Visual signals to the cortex and retina were delayed at 6 and 9 months, respectively. Surprisingly, the retinal output signal was delayed at the light onset and advanced at the light offset. This antagonistic effect, due to a dysfunction of the cone photoreceptor synapse, was associated with changes in the expression of the vesicular glutamate transporter and a microglial reaction. This dysfunction of retinal glutamatergic synapses suggests a novel interpretation for visual deficits in tauopathies and it highlights the potential value of the retina for the diagnostic assessment and the evaluation of therapies in Alzheimer's disease and other tauopathies.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice
    Liu, Mengyu
    Wang, Luwen
    Gao, Ju
    Dong, Qing
    Perry, George
    Ma, Xuemei
    Wang, Xinglong
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (04) : 1077 - 1087
  • [22] Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy
    Watt, Georgia
    Przybyla, Magdalena
    Zak, Valeria
    van Eersel, Janet
    Ittner, Arne
    Ittner, Lars M.
    Karl, Tim
    NEUROSCIENCE, 2020, 431 : 166 - 175
  • [23] Organotypic Brain Slice Cultures of Adult Transgenic P301S Mice-A Model for Tauopathy Studies
    Mewes, Agneta
    Franke, Heike
    Singer, David
    PLOS ONE, 2012, 7 (09):
  • [24] Reboxetine treatment reduces neuroinflammation and glial activation in the P301S mouse model
    Gutierrez, Irene L.
    Caso, Javier R.
    Garcia-Bueno, Borja
    Leza, Juan C.
    Madrigal, Jose L. M.
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 52 - 52
  • [25] Altered sleep and EEG power in the P301S Tau transgenic mouse model
    Holth, Jerrah K.
    Mahan, Thomas E.
    Robinson, Grace O.
    Rocha, Andreia
    Holtzman, David M.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (03): : 180 - 190
  • [26] Induction of tau pathology in a P301S mutant tau transgenic mouse model
    Suh, L.
    van Eersel, J.
    Stevens, C.
    Delerue, F.
    Bertz, J.
    Ittner, A.
    Sutherland, G.
    Ittner, L.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 277 - 277
  • [27] Overexpression of ACMSD Prevents Neuroinflammation in the P301S Tauopathy Alzheimer's Mouse Model and Improves Learning and Memory in Hippocampal-Dependent Spatial Navigation
    Meyers, K. T.
    Marmion, D. J.
    Sandoval, I. M.
    Alvarez-Rucoba, J.
    Brundin, L.
    Manfredsson, F. P.
    CELL TRANSPLANTATION, 2022, 31
  • [28] Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
    Zhu, Yan
    Zhan, Guanxia
    Fenik, Polina
    Brandes, Madison
    Bell, Patrick
    Francois, Noelle
    Shulman, Katherine
    Veasey, Sigrid
    JOURNAL OF NEUROSCIENCE, 2018, 38 (48): : 10255 - 10270
  • [29] Time-dependent progression of tauopathy and disruption of synaptic proteins in the PS19 P301S transgenic mouse
    Francois, A.
    Das Dores, G.
    Billiras, R.
    Pasteau, V.
    Iop, F.
    Girardon, S.
    Liard, C.
    Dumas, N.
    Lliopis, K.
    Gobert, A.
    Millan, M. J.
    Jeggo, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S632 - S633
  • [30] Synapse loss is an early pathological manifestation in a tauopthy model, P301S mutant tau transgenic mice
    Yoshiyama, Y
    Zhang, B
    Higuchi, M
    Trojanowski, JQ
    Lee, VM
    NEUROBIOLOGY OF AGING, 2004, 25 : S240 - S240